VALLEY FORGE, Pa., Oct.19, 2016 /PRNewswire/ -- L.E.A.F. Pharmaceuticals LLC (L.E.A.F.), an early stage, global pharmaceutical company located in Valley Forge, Pennsylvania with a mission to discover, develop and commercialize innovative and safe therapies for cancer, today announced that Dr. Clet Niyikiza, is among the Honorees of the 2016 Health Care Innovator Awards from the Philadelphia Business Journal. The award honors the people and companies who are disrupting the health care and biotechnology industries and solidifying Greater Philadelphia's reputation as a center for innovation.
"Our company name "L.E.A.F." reflects our core belief, commitment, and dedication to the value proposition of Lifting and Empowering All Families (L.E.A.F.) through the development of innovative, effective and safe medicines for patients," says Founder, President and CEO, Dr. Clet Niyikiza.
Since L.E.A.F. began operations in August 2014, the company has filed nearly a dozen patent applications to protect its intellectual property. The first utility patent was published in August 2016 by the US Patent & Trademark Office and, in February 2016, by the World Intellectual Property Organization.
"We are pleased to receive this Health Care Innovator Award because it recognizes the ongoing commitment of our team at L.E.A.F. to apply innovative approaches with state-of-the-art technological advances to the discovery and development of world-class cancer therapies in the Philadelphia area," says Niyikiza.
For more information, please visit www.leafpharmaceuticals.com.
About L.E.A.F. Pharmaceuticals
L.E.A.F. Pharmaceuticals is a global pharmaceutical company with a mission to discover, develop and commercialize innovative and safe therapies for cancer, autoimmune and infectious diseases. L.E.A.F. Pharmaceuticals does also harness scientific advances and breakthroughs in molecular biology and biochemistry, and re-engineers failed, or non-effective but yet promising molecules, with the goal to discover new, safer or more effective medicines.
Media Contact: Raffaella Lo Castro
SOURCE L.E.A.F. Pharmaceuticals LLC